Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

KOCHI: Let’s start with the basics. How important is water for health? What’s the role of the kidneys in water balance?Water ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

A team of researchers at Western Michigan University Homer Stryker M.D. School of Medicine has made a monumental breakthrough in understanding autosomal dominant polycystic kidney disease (ADPKD ...

Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications ...

Autosomal Dominant Polycystic Kidney Disease (ADPKD) affects one out of every 400 to 1,000 people, according to the release. Though the disease affects multiple parts of the body, the most notable ...